Orthofix Medical Inc. (OFIX) Financial Statements (2024 and earlier)

Company Profile

Business Address 3451 PLANO PARKWAY
LEWISVILLE, TX 75056
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments37,60749,96850,70051,66059,53671,917
Cash and cash equivalents37,60749,96850,70051,66059,53671,917
Receivables112,320113,31382,85775,63377,06972,466
Inventory, net of allowances, customer advances and progress billings222,474221,933100,150100,27797,17188,832
Inventory222,474221,933100,150100,27797,17188,832
Other undisclosed current assets26,94724,82722,28319,32521,41621,888
Total current assets:399,348410,041255,990246,895255,192255,103
Noncurrent Assets
Property, plant and equipment140,584136,81858,22957,82058,67658,513
Intangible assets, net (including goodwill)317,727324,840118,705118,830121,951121,488
Goodwill191,727202,71171,31771,31771,31771,317
Intangible assets, net (excluding goodwill)126,000122,12947,38847,51350,63450,171
Deferred income tax assets    1,5441,4541,930
Other noncurrent assets43,62845,43725,70524,57124,38324,959
Total noncurrent assets:501,939507,095202,639202,765206,464206,890
TOTAL ASSETS:901,287917,136458,629449,660461,656461,993
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities51,34945,87527,59828,00332,32227,448
Accounts payable51,34945,87527,59828,00332,32227,448
Debt678664652638624610
Other liabilities89,77791,02955,37449,00748,15160,152
Total current liabilities:141,804137,56883,62477,64881,09788,210
Noncurrent Liabilities
Long-term debt and lease obligation69,89464,06819,23919,40719,57119,730
Long-term debt, excluding current maturities51,00045,000    
Finance lease, liability18,89419,06819,23919,40719,57119,730
Liabilities, other than long-term debt49,60451,34118,90619,06619,04218,478
Other liabilities49,60451,34118,90619,06619,04218,478
Total noncurrent liabilities:119,498115,40938,14538,47338,61338,208
Total liabilities:261,302252,977121,769116,121119,710126,418
Equity
Equity, attributable to parent639,985664,159336,860333,539341,946335,575
Common stock3,6733,6472,0162,0012,0001,984
Additional paid in capital735,533721,145334,969328,387323,738318,213
Accumulated other comprehensive loss(108)(946)(1,376)(5,162)(2,821)(1,162)
Retained earnings (accumulated deficit)(99,113)(59,687)1,2518,31319,02916,540
Total equity:639,985664,159336,860333,539341,946335,575
TOTAL LIABILITIES AND EQUITY:901,287917,136458,629449,660461,656461,993

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues187,016175,204122,229113,996118,070106,418
Cost of revenue
(Cost of Goods and Services Sold)
(67,465)(64,875)(33,053)(30,573)(31,600)(28,318)
Gross profit:119,551110,32989,17683,42386,47078,100
Operating expenses(152,850)(165,909)(97,946)(86,726)(88,492)(84,677)
Other undisclosed operating income (loss)(3,333)(4,134)(2,274)(2,484)8,6633,499
Operating income (loss):(36,632)(59,714)(11,044)(5,787)6,641(3,078)
Nonoperating income (expense)(289)934,286(3,308)(3,192)(936)
Gain (loss), foreign currency transaction, before tax(269)(583)    
Other nonoperating income (expense)(20)6764,286(3,308)(3,192)(936)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (890)   
Income (loss) from continuing operations before equity method investments, income taxes:(36,921)(59,621)(7,648)(9,095)3,449(4,014)
Other undisclosed income (loss) from continuing operations before income taxes(997)(706)661(277)(407)(375)
Income (loss) from continuing operations before income taxes:(37,918)(60,327)(6,987)(9,372)3,042(4,389)
Income tax expense(1,508)(611)(75)(1,344)(553)(71)
Income (loss) from continuing operations:(39,426)(60,938)(7,062)(10,716)2,489(4,460)
Income (loss) before gain (loss) on sale of properties:(10,716)2,489(4,460)
Net income (loss) available to common stockholders, diluted:(39,426)(60,938)(7,062)(10,716)2,489(4,460)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):(39,426)(60,938)(7,062)(10,716)2,489(4,460)
Comprehensive income (loss):(39,426)(60,938)(7,062)(10,716)2,489(4,460)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent8384303,786(2,341)(1,659)(1,162)
Comprehensive income (loss), net of tax, attributable to parent:(38,588)(60,508)(3,276)(13,057)830(5,622)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: